Michael Weiser Insider Profile
4 Followers
Michael Weiser, Director at Iovance Biotherapeutics, holds 141.12K shares in Iovance Biotherapeutics (Ticker: IOVA), holds 224.28K shares in Alaunos Therapeutics (Ticker: TCRT), holds 6.41K shares in Emisphere Technologies (Ticker: ~EMIS). Most recently, Michael Weiser Bought ― shares of Iovance Biotherapeutics on Jun 02, 2022 for an estimated value of $67.98K.
Michael Weiser's Trading History
| IOVAIovance Biotherapeutics | Jun 02, 2022 | Director | Informative Buy | 67.98K | $1.14M | |
| TCRTAlaunos Therapeutics | Jan 03, 2018 | Director | Uninformative Buy | ― | $361.09K | |
| CHTPChelsea Therapeutics | Jun 25, 2014 | ― | Uninformative Sell | ― | ― | |
| TGTXTG Therapeutics | Mar 10, 2010 | Former Director | Uninformative Buy | ― | $150.74M | |
| TLONTalon Therapeutics Inc | ― | ― | ― | ― | ||
| ~EMISEmisphere Technologies | ― | ― | ― | $50.09K |
You May Also Like
Michael Weiser insider profile FAQ
What stocks does Michael Weiser hold?
Michael Weiser holds: IOVA, TCRT, ~EMIS, TGTX, CHTP, TLON stocks.
What was Michael Weiser’s latest transaction?
Michael Weiser’s latest transaction was an Informative Buy of $67.98K.
What is Michael Weiser's role in Iovance Biotherapeutics?
Michael Weiser's role in Iovance Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
